<DOC>
	<DOCNO>NCT02625545</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness use UroLift subject prostatic median lobe enlargement due BPH .</brief_summary>
	<brief_title>Study Median Lobe Prostatic UroLift Procedure</brief_title>
	<detailed_description>Study Objectives : Evaluate safety effectiveness UroLiftÂ® System use symptomatic benign prostatic hyperplasia ( BPH ) subject enlarged median lobe . Study Design : Prospective , multicenter , non-blinded , single arm ( non-randomized ) study . Sample Size : A total 40 subject enrol . Subject Population : Males age 50 year old diagnose low urinary tract symptom ( LUTS ) enlarge median lobe .</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<criteria>Enlarged median lobe ( ML ) contribute obstruction prostate BPH</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>